Presence and severity of non-alcoholic fatty liver disease in a large prospective primary care cohort
- PMID: 21703178
- DOI: 10.1016/j.jhep.2011.03.020
Presence and severity of non-alcoholic fatty liver disease in a large prospective primary care cohort
Abstract
Background & aims: Non-alcoholic fatty liver disease (NAFLD) is a common cause of abnormal LFTs in primary care, but there are no data defining its contribution nor reporting the range of NAFLD severity in this setting. This study seeks to calculate the range of disease severity of NAFLD in a primary care setting.
Methods: Adult patients with incidental abnormal LFTs, in the absence of a previous history, or current symptoms/signs of liver disease were prospectively recruited from eight primary care practices in Birmingham. NAFLD was diagnosed as fatty liver on ultrasound, negative serological liver aetiology screen, and alcohol consumption ≤30 and ≤20 g/day in males and females, respectively. The NAFLD Fibrosis Score (NFS) was calculated to determine the presence or absence of advanced liver fibrosis in subjects identified with NAFLD.
Results: Data from 1118 adult patients were analysed. The cause of abnormal LFTs was identified in 55% (614/1118) of subjects, with NAFLD (26.4%; 295/1118) and alcohol excess (25.3%; 282/1118) accounting for the majority. A high NFS (>0.676) suggesting the presence of advanced liver fibrosis was found in 7.6% of NAFLD subjects, whereas 57.2% of NAFLD patients had a low NFS (<-1.455) allowing advanced fibrosis to be confidently excluded.
Conclusions: NAFLD is the commonest cause of incidental LFT abnormalities in primary care (26.4%), of whom 7.6% have advanced fibrosis as calculated by the NFS. This study is the first of its kind to highlight the burden of NAFLD in primary care and provide data on disease severity in this setting.
Copyright © 2011 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.
Comment in
-
Touching some firm ground in the epidemiology of NASH.J Hepatol. 2012 Jan;56(1):23-5. doi: 10.1016/j.jhep.2011.08.002. Epub 2011 Aug 27. J Hepatol. 2012. PMID: 21875499 No abstract available.
Similar articles
-
NAFLD fibrosis score: a prognostic predictor for mortality and liver complications among NAFLD patients.World J Gastroenterol. 2013 Feb 28;19(8):1219-29. doi: 10.3748/wjg.v19.i8.1219. World J Gastroenterol. 2013. PMID: 23482703 Free PMC article.
-
Association between noninvasive fibrosis markers and mortality among adults with nonalcoholic fatty liver disease in the United States.Hepatology. 2013 Apr;57(4):1357-65. doi: 10.1002/hep.26156. Epub 2013 Jan 25. Hepatology. 2013. PMID: 23175136 Free PMC article.
-
Suboptimal performance of simple noninvasive tests for advanced fibrosis in Chinese patients with nonalcoholic fatty liver disease.J Dig Dis. 2012 Nov;13(11):588-95. doi: 10.1111/j.1751-2980.2012.00631.x. J Dig Dis. 2012. PMID: 23107446 Clinical Trial.
-
High NAFLD fibrosis score in non-alcoholic fatty liver disease as a predictor of carotid plaque development: a retrospective cohort study based on regular health check-up data in China.Ann Med. 2021 Dec;53(1):1621-1631. doi: 10.1080/07853890.2021.1974081. Ann Med. 2021. PMID: 34498502 Free PMC article.
-
Identification of liver disease: why and how.Frontline Gastroenterol. 2022 Jan 24;13(5):367-373. doi: 10.1136/flgastro-2021-101833. eCollection 2022. Frontline Gastroenterol. 2022. PMID: 36051960 Free PMC article. Review.
Cited by
-
Non-alcoholic liver disease in an HGV driver.London J Prim Care (Abingdon). 2015;7(1):9-11. doi: 10.1080/17571472.2015.11494373. London J Prim Care (Abingdon). 2015. PMID: 25949743 Free PMC article. No abstract available.
-
Metabolic Dysfunction-Associated Steatotic Liver Disease and Metabolic Dysfunction-Associated Steatohepatitis: The Patient and Physician Perspective.J Clin Med. 2023 Sep 26;12(19):6216. doi: 10.3390/jcm12196216. J Clin Med. 2023. PMID: 37834859 Free PMC article. Review.
-
Non-Invasive Detection of Fibrotic NASH in NAFLD Patients with Low or Intermediate FIB-4.J Clin Med. 2022 Jul 28;11(15):4394. doi: 10.3390/jcm11154394. J Clin Med. 2022. PMID: 35956017 Free PMC article.
-
Fatty liver and mortality: a cohort population study in South Italy.BMJ Open. 2019 Jun 20;9(6):e027379. doi: 10.1136/bmjopen-2018-027379. BMJ Open. 2019. PMID: 31227533 Free PMC article.
-
Nonalcoholic Fatty Liver Disease: An Important Consideration for Primary Care Providers in Hawai'i.Hawaii J Health Soc Welf. 2020 Jun 1;79(6):180-186. Hawaii J Health Soc Welf. 2020. PMID: 32524096 Free PMC article.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources